New drug aims to tame overactive thyroid in Graves' disease
Disease control
Recruiting now
This phase 2 trial tests an experimental drug called YB-101 in people with Graves' disease, an autoimmune condition that causes an overactive thyroid. The study will see if YB-101 can help normalize thyroid hormone levels and allow patients to stop taking anti-thyroid medications…
Phase: PHASE2 • Sponsor: Yarrow Bioscience, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC